BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29950003)

  • 1. Driver gene mutations based clustering of tumors: methods and applications.
    Zhang W; Flemington EK; Zhang K
    Bioinformatics; 2018 Jul; 34(13):i404-i411. PubMed ID: 29950003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying cancer driver genes in tumor genome sequencing studies.
    Youn A; Simon R
    Bioinformatics; 2011 Jan; 27(2):175-81. PubMed ID: 21169372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer driver gene discovery through an integrative genomics approach in a non-parametric Bayesian framework.
    Yang H; Wei Q; Zhong X; Yang H; Li B
    Bioinformatics; 2017 Feb; 33(4):483-490. PubMed ID: 27797769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Snowball: resampling combined with distance-based regression to discover transcriptional consequences of a driver mutation.
    Xu Y; Guo X; Sun J; Zhao Z
    Bioinformatics; 2015 Jan; 31(1):84-93. PubMed ID: 25192743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of 7,815 cancer exomes reveals associations between mutational processes and somatic driver mutations.
    Poulos RC; Wong YT; Ryan R; Pang H; Wong JWH
    PLoS Genet; 2018 Nov; 14(11):e1007779. PubMed ID: 30412573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ContrastRank: a new method for ranking putative cancer driver genes and classification of tumor samples.
    Tian R; Basu MK; Capriotti E
    Bioinformatics; 2014 Sep; 30(17):i572-8. PubMed ID: 25161249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integration of somatic mutation, expression and functional data reveals potential driver genes predictive of breast cancer survival.
    Suo C; Hrydziuszko O; Lee D; Pramana S; Saputra D; Joshi H; Calza S; Pawitan Y
    Bioinformatics; 2015 Aug; 31(16):2607-13. PubMed ID: 25810432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential analysis between somatic mutation and germline variation profiles reveals cancer-related genes.
    Przytycki PF; Singh M
    Genome Med; 2017 Aug; 9(1):79. PubMed ID: 28841835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient methods for identifying mutated driver pathways in cancer.
    Zhao J; Zhang S; Wu LY; Zhang XS
    Bioinformatics; 2012 Nov; 28(22):2940-7. PubMed ID: 22982574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OncodriveCLUST: exploiting the positional clustering of somatic mutations to identify cancer genes.
    Tamborero D; Gonzalez-Perez A; Lopez-Bigas N
    Bioinformatics; 2013 Sep; 29(18):2238-44. PubMed ID: 23884480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating the order of mutations during tumorigenesis from tumor genome sequencing data.
    Youn A; Simon R
    Bioinformatics; 2012 Jun; 28(12):1555-61. PubMed ID: 22492649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An integrative somatic mutation analysis to identify pathways linked with survival outcomes across 19 cancer types.
    Park S; Kim SJ; Yu D; Peña-Llopis S; Gao J; Park JS; Chen B; Norris J; Wang X; Chen M; Kim M; Yong J; Wardak Z; Choe K; Story M; Starr T; Cheong JH; Hwang TH
    Bioinformatics; 2016 Jun; 32(11):1643-51. PubMed ID: 26635139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovering personalized driver mutation profiles of single samples in cancer by network control strategy.
    Guo WF; Zhang SW; Liu LL; Liu F; Shi QQ; Zhang L; Tang Y; Zeng T; Chen L
    Bioinformatics; 2018 Jun; 34(11):1893-1903. PubMed ID: 29329368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DrGaP: a powerful tool for identifying driver genes and pathways in cancer sequencing studies.
    Hua X; Xu H; Yang Y; Zhu J; Liu P; Lu Y
    Am J Hum Genet; 2013 Sep; 93(3):439-51. PubMed ID: 23954162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SomInaClust: detection of cancer genes based on somatic mutation patterns of inactivation and clustering.
    Van den Eynden J; Fierro AC; Verbeke LP; Marchal K
    BMC Bioinformatics; 2015 Apr; 16():125. PubMed ID: 25903787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of different functional prediction scores using a gene-based permutation model for identifying cancer driver genes.
    Nono AD; Chen K; Liu X
    BMC Med Genomics; 2019 Jan; 12(Suppl 1):22. PubMed ID: 30704472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of signals of positive and negative selection to distinguish cancer genes and passenger genes.
    Bányai L; Trexler M; Kerekes K; Csuka O; Patthy L
    Elife; 2021 Jan; 10():. PubMed ID: 33427197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OncoVar: an integrated database and analysis platform for oncogenic driver variants in cancers.
    Wang T; Ruan S; Zhao X; Shi X; Teng H; Zhong J; You M; Xia K; Sun Z; Mao F
    Nucleic Acids Res; 2021 Jan; 49(D1):D1289-D1301. PubMed ID: 33179738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OncodriveROLE classifies cancer driver genes in loss of function and activating mode of action.
    Schroeder MP; Rubio-Perez C; Tamborero D; Gonzalez-Perez A; Lopez-Bigas N
    Bioinformatics; 2014 Sep; 30(17):i549-55. PubMed ID: 25161246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Driver gene detection through Bayesian network integration of mutation and expression profiles.
    Chen Z; Lu Y; Cao B; Zhang W; Edwards A; Zhang K
    Bioinformatics; 2022 May; 38(10):2781-2790. PubMed ID: 35561191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.